Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating autologous bone marrow-derived mononuclear cells with liberation therapy for CCSVI in relapsing-remitting…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design
A pilot crossover study evaluating disease stability in Relapsing Remitting Multiple Sclerosis by switching between natalizumab and dimethyl…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment
This clinical trial update reports on an observational study evaluating how nurse support and disease factors influence long-term adherence …
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Vitamin D Pilot Study in Patients With Multiple Sclerosis [Phase 1]
Phase 1 pilot trial evaluating Vitamin D (cholecalciferol) in Relapsing Remitting Multiple Sclerosis has completed.
-
CLINICAL_TRIALS withdrawal · 2015-09-07Clinical Trial Update: Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl Fumarate [Phase 4]
A Phase 4 clinical trial evaluating fatigue in people with relapsing-remitting multiple sclerosis treated with dimethyl fumarate has been wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Melatonin in Relapsing-Remitting Multiple Sclerosis Patients [Phase 2]
Phase 2 clinical trial evaluating melatonin in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Phase I BP Interferon (IFN) Beta-004 [Phase 1]
Phase I trial update shows BP Interferon Beta-004 in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Phase I BP Interferon (IFN) Beta-001 [Phase 1]
Phase I trial update for BP Interferon Beta-001 in relapsing-remitting multiple sclerosis, with Phase 1 completed.
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS) [Phase 2]
A Phase 2 exploratory study evaluating multiple regimens of Natalizumab in adults with Relapsing-Remitting Multiple Sclerosis has completed.…
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)
A completed clinical trial evaluating how Betaferon injection management influences adherence, patient satisfaction, and health-related outc…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change [Phase 4]
Phase 4 clinical trial in relapsing-remitting multiple sclerosis evaluating candidates for changing MS therapy; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis [Phase 2]
Biogen's BG00012 (dimethyl fumarate) Phase 2 combination trial in multiple sclerosis has completed, with results posted in June 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Natalizumab (Tysabri) Re-Initiation of Dosing [Phase 3]
The Phase 3 trial of natalizumab (Tysabri) for relapsing-remission multiple sclerosis was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating SB683699 in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells [Phase 1, Phase 2]
Phase 1/2 trial evaluating tolerance induction in relapsing-remitting multiple sclerosis using autologous peptide-coupled peripheral blood m…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses [Phase 2]
This completed Phase 2 study updates the long-term safety and efficacy of teriflunomide (HMR1726) in relapsing multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]
This update reports safety and tolerability results from a Phase 3 trial of fingolimod in patients with relapsing-remitting multiple scleros…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Mass Balance Study of MT-1303 [Phase 1]
The document reports the completion of a Phase 1 mass balance study of MT-1303 in relapsing-remitting multiple sclerosis. The trial was spon…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Comparative Oral Bioavailability Study of MT-1303 [Phase 1]
Phase 1 study update evaluating the comparative oral bioavailability of MT-1303 in Relapsing-remitting Multiple Sclerosis has been completed…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler [Phase 2]
Phase 2 MRI-based trial for relapsing-remitting multiple sclerosis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 [Phase 1]
This document reports a completed Phase 1 study evaluating the cardiac pharmacodynamics of MT-1303 in relapsing-remitting multiple sclerosis…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis [Phase 1]
Phase 1 clinical trial update for ATX-MS-1467 in relapsing-remitting multiple sclerosis; the study is completed and results have been posted…
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Adherence Trial With MS LifeLines ® Services
The Adherence Trial With MS LifeLines Services sponsored by EMD Serono has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS [Phase 4]
Phase 4 head-to-head trial comparing two marketed therapies for relapsing-remitting multiple sclerosis has completed, assessing efficacy and…
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya [Phase 4]
A Phase 4 clinical trial evaluating immune function and MRI disease activity in relapsing-remitting multiple sclerosis patients switching fr…